Clinical trial
P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery…
NCT00393315 · University Hospital, Saarland, Other · Completed
Key facts
| NCT number | NCT00393315 |
|---|---|
| Title | P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses |
| Official title | P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses: A Comparison to the Paclitaxel-Eluting Taxus™ Stent. A Pilot Study |
| Lead sponsor | University Hospital, Saarland, Other |
| Collaborators | B. Braun Melsungen AG Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | In-Stent Restenosis |
| Intervention type | Device |
| Interventions | paclitaxel coated balloon catheter |
| Enrollment | 120 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Oct 27, 2006 |
| Last update posted | Jun 30, 2010 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: